Thank you for that.
My second question is for Mr. Elliott.
You talk about this policy space. For us as parliamentarians, this is incredibly important if we're actually going to improve public health and advocate for public safety. Eventually, I would love to see a pharmacare program happen. That public space is going to be limited under these trade agreements, and certainly under the TPP.
At the end of your presentation, you started talking about how it will lock us into certain things. One of the things you mentioned was linkage regulations. Could you expand on some of those things that we'd be locked into?